MedPath
FDA Approval

Naproxen Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 11, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(550 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naproxen Sodium

Product Details

NDC Product Code
54868-3043
Application Number
ANDA078314
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 11, 2012
NaproxenActive
Code: 9TN87S3A3CClass: ACTIBQuantity: 550 mg in 1 1
POVIDONEInactive
Code: FZ989GH94EClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT

Naproxen Sodium

Product Details

NDC Product Code
54868-3359
Application Number
ANDA078314
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 11, 2012
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
NaproxenActive
Code: 9TN87S3A3CClass: ACTIBQuantity: 275 mg in 1 1
POVIDONEInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath